Clinical Trial Update: To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of GSK2256294 on pulmonary artery pressure in healthy volunteers under normoxic and hypoxic conditions; the study is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK2256294 (GSK2256294)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED